INOVIO INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inovio Pharmaceuticals Inc. - INO
INOVIO INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inovio Pharmaceuticals Inc. - INO
NEW ORLEANS,March 12, 2021/PRNewswire/ -- Former Attorney General ofLouisiana,Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF continues its investigation into Inovio Pharmaceuticals Inc. (NasdaqGS: INO).
亞洲網新奧爾良2021年3月12日電Kahn Swick&Foti，LLC(以下簡稱“KSF”)律師事務所合夥人、路易斯安那州前司法部長小查爾斯·C·福蒂(Charles C.Foti，Jr.，Esq.)宣佈，KSF繼續對Inovio製藥公司(納斯達克市場代碼：INO)進行調查。
OnMarch 9, 2020Citron Research published a statement highlighting the Company's "ludicrous and dangerous claim that they designed a [COVID-19] vaccine in 3 hours" and calling for an SEC investigation into the claims. That same day, the Company disclosed that its purported COVID-19 vaccine, which had been developed "within three hours," was not a fully-fledged vaccine at all, but merely a construct for a vaccine.
2020年3月9日，Citron Research發表了一份聲明，強調了該公司“荒謬而危險的説法，即他們設計了一個[新冠肺炎]該公司表示，“3小時內就能生產出疫苗”，並要求美國證券交易委員會對這一説法進行調查。就在同一天，該公司披露，其所謂的“3小時內”研發出的新冠肺炎疫苗根本不是一種完全成熟的疫苗，而僅僅是一種疫苗的構建。
Thereafter, the Company and certain of its executives were sued in a securities class action lawsuit, charging them with failing to disclose material information during the Class Period, violating federal securities laws. Recently, the court in that case denied the Company's motion to dismiss in part, allowing the case to move forward.
此後，該公司及其某些高管在證券集體訴訟中被起訴，指控他們在證券集體訴訟期間未能披露重要信息，違反了聯邦證券法。最近，該案件的法院駁回了該公司的部分駁回動議，允許案件繼續進行。
KSF's investigation is focusing on whether Inovio's officers and/or directors breached their fiduciary duties to Inovio's shareholders or otherwise violated state or federal laws.
KSF的調查重點是Inovio的高管和/或董事是否違反了他們對Inovio股東的受託責任，或者是否違反了州或聯邦法律。
If you have information that would assist KSF in its investigation, or have been a long-term holder of Inovio shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nasdaqgs-ino/ to learn more.
如果您有有助於KSF調查的信息，或者您是英諾威股份的長期持有者，並想討論您的合法權利，您可以免費撥打1-877-515-1850，或給KSF管理合夥人劉易斯·卡恩發電子郵件(lewis.kahn@ksfconsult.com)，或訪問https://www.ksfcounsel.com/cases/nasdaqgs-ino/瞭解更多信息，您可以在沒有義務或費用的情況下撥打免費電話1-877-515-1850，或向KSF管理合夥人劉易斯·卡恩發送電子郵件，瞭解更多信息。
About Kahn Swick & Foti, LLC
關於Kahn Swick&Foti，LLC
KSF, whose partners include formerLouisianaAttorney GeneralCharles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, money managers and retail investors – in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies. KSF has offices inNew York,CaliforniaandLouisiana.
KSF的合作伙伴包括前路易斯安那州總檢察長小查爾斯·C·福蒂(Charles C.Foti，Jr.)，是美國首屈一指的精品證券訴訟律師事務所之一。KSF為包括公共機構投資者、對衝基金、基金經理和散户投資者在內的各種客户提供服務，以尋求追回因上市公司欺詐和瀆職而造成的投資損失。KSF在紐約、加利福尼亞州和路易斯安那州設有辦事處。
To learn more about KSF, you may visit www.ksfcounsel.com.
要了解更多關於KSF的信息，您可以訪問www.ksfconsult.com。
Contact:
聯繫方式：
Kahn Swick & Foti, LLC
Kahn Swick&Foti，LLC
Lewis Kahn, Managing Partner
劉易斯·卡恩(Lewis Kahn)，管理合夥人
lewis.kahn@ksfcounsel.com
郵箱：lewis.kahn@ksfconsult.com
1-877-515-1850
1-877-515-1850
1100 Poydras St., Suite 3200
1100 Poydras街，3200套房
New Orleans, LA70163
新奧爾良，郵編：LA70163
View original content to download multimedia:http://www.prnewswire.com/news-releases/inovio-investigation-continued-by-former-louisiana-attorney-general--kahn-swick--foti-llc-continues-to-investigate-the-officers-and-directors-of-inovio-pharmaceuticals-inc---ino-301246219.html
查看原創內容以下載multimedia:http://www.prnewswire.com/news-releases/inovio-investigation-continued-by-former-louisiana-attorney-general--kahn-swick--foti-llc-continues-to-investigate-the-officers-and-directors-of-inovio-pharmaceuticals-inc---ino-301246219.html
SOURCE Kahn Swick & Foti, LLC
來源：Kahn Swick&Foti，LLC
譯文內容由第三人軟體翻譯。